| scholarly article | Q13442814 |
| P2093 | author name string | Nicholas Moore | |
| P2860 | cites work | Power and weakness of spontaneous reporting: a probabilistic approach | Q68101463 |
| Adverse Drug Reaction Monitoring Program | Q68278670 | ||
| [Pharmacovigilance in the hospital. First results] | Q68545715 | ||
| [Pharmacovigilance in the framework of recording and control of drugs in the United Kingdom] | Q68901101 | ||
| QT prolongation and torsade de pointes ventricular tachycardia produced by Ketanserin | Q68981738 | ||
| [Information centers on undesirable effects of drugs: also on alerting function] | Q69174376 | ||
| Adverse-drug-reaction monitoring | Q69522196 | ||
| Adverse drug reaction monitoring: doing it the French way | Q69872137 | ||
| Comparing the toxicity of two drugs in the framework of spontaneous reporting: a confidence interval approach | Q70994189 | ||
| Cough and ACE inhibitors | Q72207759 | ||
| Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use | Q73487778 | ||
| Comment on 'Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use' Tramer et al., Pain 2000;85:169-182 | Q73949595 | ||
| Incidence of serious adverse drug reactions in general practice: a prospective study | Q74020853 | ||
| Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system | Q77425506 | ||
| Rates of spontaneous reporting of adverse drug reactions in France | Q78288415 | ||
| Educating European (junior) doctors for safe prescribing | Q81419718 | ||
| The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions | Q81554845 | ||
| Clinical pharmacology in research, teaching and health care: Considerations by IUPHAR, the International Union of Basic and Clinical Pharmacology | Q84507174 | ||
| Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients | Q28169189 | ||
| Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus | Q28295644 | ||
| A method for estimating the probability of adverse drug reactions | Q29616247 | ||
| A data mining approach for signal detection and analysis | Q30699387 | ||
| Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post‐marketing setting | Q30881243 | ||
| Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death | Q33152239 | ||
| Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA. | Q33439923 | ||
| Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users. | Q33692833 | ||
| Patterns and correlates of benzodiazepine use in the French general population | Q33980983 | ||
| Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports | Q34112790 | ||
| Active safety monitoring of new medical products using electronic healthcare data: selecting alerting rules | Q34135347 | ||
| Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry | Q34154285 | ||
| Spontaneous reporting: how many cases are required to trigger a warning? | Q34358944 | ||
| Impact of a focussed teaching programme on practical prescribing skills among final year medical students | Q34476064 | ||
| Case-population studies in pharmacoepidemiology. | Q34512879 | ||
| Agranulocytosis associated with calcium dobesilate clinical course and risk estimation with the case-control and the case-population approaches | Q34513698 | ||
| A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. | Q34629802 | ||
| Drug hypersensitivity: pharmacogenetics and clinical syndromes | Q34701492 | ||
| Antipsychotic-related QTc prolongation, torsade de pointes and sudden death | Q34730759 | ||
| Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability. | Q35114141 | ||
| Clinical Pharmacology Education in Europe: Undergraduate through Postgraduate to Continuing Professional Development | Q35587377 | ||
| Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database | Q35714366 | ||
| Frequency and cost of serious adverse drug reactions in a department of general medicine | Q35802171 | ||
| The reporting odds ratio and its advantages over the proportional reporting ratio | Q35865910 | ||
| Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses | Q36060576 | ||
| Under-reporting of adverse drug reactions in general practice | Q36093893 | ||
| Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes. | Q36131480 | ||
| Drug-induced QT interval prolongation--regulatory guidance and perspectives on hERG channel studies. | Q36210671 | ||
| Learning curves, taking instructions, and patient safety: using a theoretical domains framework in an interview study to investigate prescribing errors among trainee doctors | Q36539116 | ||
| Effect of increased warfarin use on warfarin-related cerebral hemorrhage: a longitudinal population-based study. | Q51167842 | ||
| Communication in drug safety: a report from an interactive debate held at the 10th annual meeting of the international society of pharmacovigilance (ISoP), 2010. | Q51169048 | ||
| Methodology for a multinational case-population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT). | Q51190369 | ||
| Healthcare professionals' self-reported experiences and preferences related to direct healthcare professional communications: a survey conducted in the Netherlands. | Q51310674 | ||
| Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system. | Q51440489 | ||
| Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre. | Q51650731 | ||
| Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department. | Q51933528 | ||
| A new method for assessing drug causation provided agreement with experts' judgment. | Q51949776 | ||
| A Bayesian approach to causality assessment. | Q52076627 | ||
| A Bayesian neural network method for adverse drug reaction signal generation. | Q52238255 | ||
| Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France. | Q53105748 | ||
| Serum sickness-like reactions to cefaclor. | Q53393338 | ||
| The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study. | Q53897535 | ||
| European network for the case-population surveillance of rare diseases (Euronet). A prospective feasibility study. | Q55067432 | ||
| Post-marketing surveillance of adverse reactions to new medicines | Q55342932 | ||
| THALIDOMIDE AND CONGENITAL ABNORMALITIES | Q56486313 | ||
| Genetics and the Potential for Predictive Tests in Adverse Drug Reactions | Q57302670 | ||
| A potential competition bias in the detection of safety signals from spontaneous reporting databases | Q57521230 | ||
| The New Sentinel Network — Improving the Evidence of Medical-Product Safety | Q61836841 | ||
| The reporting odds ratio versus the proportional reporting ratio:‘deuce’ | Q63865876 | ||
| Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case-population SALT study | Q36597715 | ||
| The influence of primary care prescribing rates for new drugs on spontaneous reporting of adverse drug reactions | Q36780091 | ||
| Undergraduate preparation for prescribing: the views of 2413 UK medical students and recent graduates | Q36792783 | ||
| Novel statistical tools for monitoring the safety of marketed drugs | Q36835511 | ||
| Warfarin dose prediction in children using pharmacometric bridging--comparison with published pharmacogenetic dosing algorithms | Q36836979 | ||
| Bayesian confidence propagation neural network | Q36866517 | ||
| Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres | Q37324712 | ||
| Case series in drug safety: a review to determine characteristics and quality | Q37809529 | ||
| Proarrhythmic actions of antiarrhythmic drugs: a review | Q37942028 | ||
| Impact of safety-related regulatory action on clinical practice: a systematic review. | Q38000336 | ||
| A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009. | Q39871580 | ||
| Teaching basic and clinical pharmacology to medical students: a 2006 survey in French schools of medicine | Q40249491 | ||
| False-positives in spontaneous reporting: should we worry about them? | Q40614212 | ||
| Harmonisation in pharmacovigilance | Q40661017 | ||
| Is reporting rate a good predictor of risks associated with drugs? | Q40816305 | ||
| Drug-related hospital admissions | Q40842331 | ||
| A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confounding | Q40944247 | ||
| Random models for margins of a 2 x 2 contingency table and application to pharmacovigilance | Q41158958 | ||
| Drug-induced cardiac arrhythmias: incidence, prevention and management | Q41628830 | ||
| Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study. | Q42162410 | ||
| Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database | Q42281184 | ||
| Assessing drug safety | Q42939005 | ||
| A pharmacometric model describing the relationship between warfarin dose and INR response with respect to variations in CYP2C9, VKORC1, and age. | Q43089518 | ||
| Poor prescribing is continual | Q43249018 | ||
| The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot program | Q43433884 | ||
| High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications. | Q43701143 | ||
| Prescribing of rosiglitazone and pioglitazone following safety signals: analysis of trends in dispensing patterns in the Netherlands from 1998 to 2008. | Q43703608 | ||
| Computerized comparison of six adverse drug reaction assessment procedures | Q43755137 | ||
| Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias | Q43761720 | ||
| Relevance of a "Dear Doctor letter" to alert healthcare providers to new recommendations for vitamin D administration | Q43799079 | ||
| An updated method improved the assessment of adverse drug reaction in routine pharmacovigilance | Q43932720 | ||
| Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France | Q43965677 | ||
| Developing the Sentinel System--a national resource for evidence development | Q44120843 | ||
| Factors associated with serious traffic crashes: a prospective study in southwest France | Q44203170 | ||
| Minor head injury in warfarinized patients: indicators of risk for intracranial hemorrhage | Q44235538 | ||
| Food and Drug Administration's adverse drug reaction monitoring program | Q44270918 | ||
| Biases affecting the proportional reporting ratio (PPR) in spontaneous reports pharmacovigilance databases: the example of sertindole | Q44481511 | ||
| Design considerations in an active medical product safety monitoring system. | Q44659710 | ||
| EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection | Q44668093 | ||
| Perceived causes of prescribing errors by junior doctors in hospital inpatients: a study from the PROTECT programme | Q44730861 | ||
| Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France. | Q44771754 | ||
| The EU-ADR project: preliminary results and perspective. | Q44943759 | ||
| Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals | Q45371649 | ||
| Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. | Q45915951 | ||
| The case-population study design: an analysis of its application in pharmacovigilance | Q46061087 | ||
| Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System. | Q46108574 | ||
| The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction | Q46362415 | ||
| Benzodiazepines and injurious falls in community dwelling elders | Q46816323 | ||
| Impact of safety-related regulatory action on drug use in ambulatory care in the Netherlands. | Q47947189 | ||
| P304 | page(s) | 33-41 | |
| P577 | publication date | 2013-05-03 | |
| P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
| P1476 | title | The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist | |
| P478 | volume | 69 Suppl 1 |
| Q40160191 | A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases |
| Q47779429 | Can drugs induce or aggravate sleep apneas? A case-noncase study in VigiBase® , the WHO pharmacovigilance database |
| Q57488986 | Comparative evaluation of pharmacovigilance regulation of the United States, United Kingdom, Canada, India and the need for global harmonized practices |
| Q38793916 | Methods for safety signal detection in healthcare databases: a literature review |
| Q43897779 | Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluation. |
| Q47732295 | Pharmacovigilance: empowering healthcare professionals and patients |
Search more.